Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Teva
Cipla
Cantor Fitzgerald
Covington
UBS
Fish and Richardson
Chinese Patent Office
Moodys

Generated: January 21, 2018

DrugPatentWatch Database Preview

Sodium benzoate; sodium phenylacetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for sodium benzoate; sodium phenylacetate and what is the scope of sodium benzoate; sodium phenylacetate patent protection?

Sodium benzoate; sodium phenylacetate
is the generic ingredient in three branded drugs marketed by Medicis, Ailex Pharms Llc, Maia Pharms Inc, Navinta Llc, and B Braun, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and fifteen drug master file entries for sodium benzoate; sodium phenylacetate. Seven suppliers are listed for this compound.
Summary for sodium benzoate; sodium phenylacetate
Pharmacology for sodium benzoate; sodium phenylacetate

US Patents and Regulatory Information for sodium benzoate; sodium phenylacetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis AMMONUL sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 020645-001 Feb 17, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Navinta Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 205880-001 Aug 4, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ailex Pharms Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 207096-001 Feb 24, 2016 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;IV (INFUSION) 208521-001 May 8, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
B Braun UCEPHAN sodium benzoate; sodium phenylacetate SOLUTION;ORAL 019530-001 Dec 23, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Boehringer Ingelheim
Covington
Chubb
QuintilesIMS
Harvard Business School
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot